Risk Factors for Weight Gain Following Switch to Integrase Inhibitor-Based Antiretroviral Therapy
Open Access
- 26 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 71 (9), E471-E477
- https://doi.org/10.1093/cid/ciaa177
Abstract
Background. Treatment initiation with integrase strand transfer inhibitors (INSTIs) has been associated with excess weight gain. Whether similar gains are seen after switch to INSTIs among virologically suppressed persons is less clear. We assessed pre/post-INSTI weight changes from AIDS Clinical Trials Group participants (A5001 and A5322). Methods. Participants who were in follow-up from 1997-2017 and switched to INSTI-based antiretroviral regimens were included. Piecewise linear mixed-effects models adjusting for age, sex, race/ethnicity, baseline BMI, nadir and current CD4(+) T-cell count, smoking, diabetes and follow-up time with suppressed HIV-1 RNA examined weight and waist circumference change before and after first switch to INSTIs. Linear spline models with a single knot at time of switch accounted for nonlinear trends. Results. The 972 participants who switched to INSTIs were 81% male and 50% nonwhite with a median age at switch of 50 years, CD4(+) T-cell count 512 cells/mu L, and BMI 26.4 kg/m(2). Restricting to persons with suppressed HIV-1 RNA at switch (n = 691), women, blacks, and persons >= 60 years experienced greater weight gain in the 2 years after versus before switch. In adjusted models, white or black race, age >= 60, and BMI >= 30 kg/m(2) at switch were associated with greater weight gain following switch among women; age >= 60 was the greatest risk factor among men. Trends for waist circumference were similar. Conclusions. Yearly weight gain increased following switch to INSTIs, particularly for women, blacks, and persons aged >= 60. Concomitant increases in waist circumference suggest that this weight gain is associated with an increase in fat mass.Funding Information
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (K23AI110532, UM1 AI068634, UM1 AI068636, UM1 AI106701)
- National Institute on Aging (R01 AG054366)
This publication has 19 references indexed in Scilit:
- Leptin expression in HIV-infected patients during antiretroviral therapyGERMS, 2015
- Neural Control of Energy Balance: Translating Circuits to TherapiesCell, 2015
- Adipose Tissue Resting Energy Expenditure and Expression of Genes Involved in Mitochondrial Function Are Higher in Women than in MenJournal of Clinical Endocrinology & Metabolism, 2013
- Neurochemical Characterization and Sexual Dimorphism of Projections from the Brain to Abdominal and Subcutaneous White Adipose Tissue in the RatJournal of Neuroscience, 2012
- AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT): Rationale, Design, and Baseline CharacteristicsHIV Research & Clinical Practice, 2008
- Sexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasisAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Anatomy and regulation of the central melanocortin systemNature Neuroscience, 2005
- Depot- and Sex-Specific Differences in Human Leptin mRNA Expression: Implications for the Control of Regional Fat DistributionDiabetes, 1997
- Sexual Dimorphism in Plasma Leptin Concentration1Journal of Clinical Endocrinology & Metabolism, 1997
- Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in MiceCell, 1997